{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:08:19Z","timestamp":1788815299876,"version":"build-2803163510"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["202408420047"],"award-info":[{"award-number":["202408420047"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["202209210023"],"award-info":[{"award-number":["202209210023"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004033","name":"Johannes Gutenberg-Universit\u00e4t Mainz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bcp.2026.118353","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:29:43Z","timestamp":1786548583000},"page":"118353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["Discovery of NAT-6-321056 as a novel modulator of VEGFR2 signaling to suppress tumor angiogenesis"],"prefix":"10.1016","volume":"253","author":[{"given":"Xiao","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Wiesmann-Imilowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shila","family":"Prajapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Guthart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine M.","family":"Klauck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elbadawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letian","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Efferth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118353_b0005","first-page":"198","article-title":"Angiogenic signaling pathways and anti-angiogenic therapy for cancer, Signal Transduct.","volume":"8","author":"Liu","year":"2023","journal-title":"Target. Ther."},{"key":"10.1016\/j.bcp.2026.118353_b0010","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.3390\/jcm13154332","article-title":"Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) rs2071559 gene polymorphism and the risk of gliomas: a systematic review and meta-analysis","volume":"13","author":"Prasetiyo","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bcp.2026.118353_b0015","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/84635","article-title":"VEGF-D promotes the metastatic spread of tumor cells via the lymphatics","volume":"7","author":"Stacker","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2026.118353_b0020","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrm.2016.87","article-title":"Mechanisms and regulation of endothelial VEGF receptor signalling","volume":"17","author":"Simons","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2026.118353_b0025","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s12035-020-01892-8","article-title":"Tumor development and angiogenesis in adult brain tumor: Glioblastoma","volume":"57","author":"Ahir","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bcp.2026.118353_b0030","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.3390\/clinpract12060108","article-title":"Implications of cellular immaturity in necrosis and microvascularization in glioblastomas IDH-wild-yype","volume":"12","author":"Orasanu","year":"2022","journal-title":"Clin. Pract."},{"key":"10.1016\/j.bcp.2026.118353_b0035","series-title":"Angiogenesis an integrative approach from science to medicine","first-page":"205","article-title":"VEGF signal tranduction in angiogenesis","author":"Kawamura","year":"2008"},{"issue":"3","key":"10.1016\/j.bcp.2026.118353_b0040","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.critrevonc.2007.01.006","article-title":"Vascular endothelial growth factor (VEGF) signaling in tumor progression","volume":"62","author":"Roskoski","year":"2007","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bcp.2026.118353_b0045","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.celrep.2017.01.051","article-title":"The mTOR and PP2A pathways regulate PHD2 phosphorylation to fine-tune HIF1\u03b1 levels and colorectal cancer cell survival under hypoxia","volume":"18","author":"Di Conza","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2026.118353_b0050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0006-2952(99)00292-0","article-title":"Expression of hypoxia-inducible factor 1: mechanisms and consequences","volume":"59","author":"Semenza","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118353_b0055","doi-asserted-by":"crossref","first-page":"14324","DOI":"10.3390\/ijms232214324","article-title":"Paracrine and autocrine effects of VEGF are enhanced in human eMSC spheroids","volume":"23","author":"Kozhukharova","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bcp.2026.118353_b0060","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/wsbm.92","article-title":"Systems biology of pro-angiogenic therapies targeting the VEGF system","volume":"2","author":"Mac Gabhann","year":"2010","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"issue":"7070","key":"10.1016\/j.bcp.2026.118353_b0065","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature04483","article-title":"Angiogenesis as a therapeutic target","volume":"438","author":"Ferrara","year":"2005","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2026.118353_b0070","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/ijms14010088","article-title":"The role of the VEGF-C\/VEGFRs axis in tumor progression and therapy","volume":"14","author":"Chen","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118353_b0075","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.prp.2015.04.003","article-title":"Expression and prognostic significance of VEGFR-2 in breast cancer","volume":"211","author":"Yan","year":"2015","journal-title":"Pathol. Res. Pract."},{"issue":"3","key":"10.1016\/j.bcp.2026.118353_b0080","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1582-4934.2009.00941.x","article-title":"A systems biology perspective on SVEGFR1: Its biological function, pathogenic role and therapeutic use","volume":"14","author":"Wu","year":"2010","journal-title":"J. Cell. Mol. Med."},{"issue":"3","key":"10.1016\/j.bcp.2026.118353_b0085","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/sj.bjc.6602374","article-title":"Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer","volume":"92","author":"Bando","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bcp.2026.118353_b0090","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2334\/josnusd.51.551","article-title":"VEGFR2 expression and relationship between tumor neovascularization and histologic characteristics in oral squamous cell carcinoma","volume":"51","author":"Sato","year":"2009","journal-title":"J. Oral Sci."},{"key":"10.1016\/j.bcp.2026.118353_b0095","doi-asserted-by":"crossref","first-page":"1571153","DOI":"10.3389\/fphar.2025.1571153","article-title":"Pharmacological effects, molecular mechanisms, and pharmacokinetics of benzoylaconine: a systematic review","volume":"16","author":"Zhuang","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.bcp.2026.118353_b0100","first-page":"1528","article-title":"Privileged scaffolds or promiscuous binders: a glance of pyrrolo[2,1-f][1,2,4]triazines and related bridgehead nitrogen heterocycles in medicinal chemistry","volume":"19","author":"Song","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bcp.2026.118353_b0105","doi-asserted-by":"crossref","first-page":"109587","DOI":"10.1016\/j.biopha.2019.109587","article-title":"Efficacy and safety of the VEGFR2 inhibitor Apatinib for metastatic soft tissue sarcoma: chinese cohort data from NCT03121846","volume":"122","author":"Liu","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2026.118353_b0110","doi-asserted-by":"crossref","first-page":"106678","DOI":"10.1016\/j.bioorg.2023.106678","article-title":"Novel VEGFR-2 inhibitors as antiangiogenic and apoptotic agents via paracrine and autocrine cascades: Design, synthesis, and biological evaluation","volume":"139","author":"Abdel Rahman","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"10","key":"10.1016\/j.bcp.2026.118353_b0115","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/aps.2012.76","article-title":"The important roles of RET, VEGFR2 and the RAF\/MEK\/ERK pathway in cancer treatment with sorafenib","volume":"33","author":"Mao","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bcp.2026.118353_b0120","doi-asserted-by":"crossref","first-page":"116472","DOI":"10.1016\/j.ejmech.2024.116472","article-title":"Recent advances and future directions on small molecule VEGFR inhibitors in oncological conditions","volume":"272","author":"Thakur","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2026.118353_b0125","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bbcan.2014.05.002","article-title":"Angiogenic factors as potential drug target: efficacy and limitations of anti-angiogenic therapy","volume":"1846","author":"Gacche","year":"2014","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.bcp.2026.118353_b0130","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1146\/annurev-physiol-020518-114700","article-title":"Normalizing function of tumor vessels: progress, opportunities, and challenges","volume":"81","author":"Martin","year":"2019","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.bcp.2026.118353_b0135","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00018-019-03351-7","article-title":"Tumor angiogenesis: causes, consequences, challenges and opportunities","volume":"77","author":"Lugano","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bcp.2026.118353_b0140","doi-asserted-by":"crossref","first-page":"104359","DOI":"10.1016\/j.compbiomed.2021.104359","article-title":"Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning","volume":"133","author":"Kadioglu","year":"2021","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.bcp.2026.118353_b0145","doi-asserted-by":"crossref","first-page":"118246","DOI":"10.1016\/j.biopha.2025.118246","article-title":"Identification of nsp16 inhibitors of SARS-CoV-2, SARS-CoV-1 and MERS-CoV from FDA-approved drugs using in silico and in vitro methods","volume":"189","author":"Omer","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2026.118353_b0150","doi-asserted-by":"crossref","first-page":"117841","DOI":"10.1016\/j.biopha.2025.117841","article-title":"Diketopiperazine\/piperidine alkaloid as a potential broad-spectrum coronaviral entry inhibitor identified by supercomputer-based virtual screening from a large natural product-based library","volume":"183","author":"Shahhamzehei","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2026.118353_b0155","doi-asserted-by":"crossref","first-page":"105621","DOI":"10.1016\/j.tvjl.2021.105621","article-title":"Evaluation of ponatinib in vitro effect in three canine mast cell tumor cell lines expressing FGFR-1, PDGFR-\u03b1, and VEGFR-2","volume":"269","author":"Fisher","year":"2021","journal-title":"Vet. J."},{"key":"10.1016\/j.bcp.2026.118353_b0160","doi-asserted-by":"crossref","first-page":"152890","DOI":"10.1016\/j.phymed.2019.152890","article-title":"Collateral sensitivity of drug-resistant ABCB5- and mutation-activated EGFR overexpressing cells towards resveratrol due to modulation of SIRT1 expression","volume":"59","author":"Saeed","year":"2019","journal-title":"Phytomedicine"},{"issue":"7","key":"10.1016\/j.bcp.2026.118353_b0165","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00424-023-02825-9","article-title":"The role of acrolein for E-cigarette vapour condensate mediated activation of NADPH oxidase in cultured endothelial cells and macrophages","volume":"475","author":"Kuntic","year":"2023","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.bcp.2026.118353_b0170","doi-asserted-by":"crossref","first-page":"114788","DOI":"10.1016\/j.bcp.2021.114788","article-title":"Cytotoxicity of 4-hydroxy-N-(naphthalen-1-yl)-2-oxo-2H-chromene-3-carboxamide in multidrug-resistant cancer cells through activation of PERK\/eIF2\u03b1\/ATF4 pathway","volume":"193","author":"Lu","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"12","key":"10.1016\/j.bcp.2026.118353_b0175","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1073\/pnas.80.12.3734","article-title":"Permanent cell line expressing human factor VIII-related antigen established by hybridization","volume":"80","author":"Edgell","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2026.118353_b0180","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s10637-019-00810-7","article-title":"Vitamin K3 thio-derivative: a novel specific apoptotic inducer in the doxorubicin-sensitive and -resistant cancer cells","volume":"38","author":"Hegazy","year":"2020","journal-title":"Invest. New Drugs"},{"issue":"20","key":"10.1016\/j.bcp.2026.118353_b0185","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1021\/acs.jcim.3c01153","volume":"63","author":"Case","year":"2023","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bcp.2026.118353_b0190","series-title":"Amber 2024","author":"Case","year":"2024"},{"issue":"12","key":"10.1016\/j.bcp.2026.118353_b0195","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N-log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"issue":"7","key":"10.1016\/j.bcp.2026.118353_b0200","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data","volume":"9","author":"Roe","year":"2013","journal-title":"J. Chem. Theory Comput."},{"issue":"5","key":"10.1016\/j.bcp.2026.118353_b0205","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.bcp.2026.118353_b0210","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/ct300418h","article-title":"MMPBSA.py: an efficient program for end-state free energy calculations","volume":"8","author":"Miller","year":"2012","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.bcp.2026.118353_b0215","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/prot.20033","article-title":"Exploring protein native states and large-scale conformational changes with a modified generalized born model","volume":"55","author":"Onufriev","year":"2004","journal-title":"Proteins"},{"key":"10.1016\/j.bcp.2026.118353_b0220","doi-asserted-by":"crossref","first-page":"W5","DOI":"10.1093\/nar\/gkab255","article-title":"ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties","volume":"49","author":"Xiong","year":"2021","journal-title":"Nucleic. Acids Res."},{"key":"10.1016\/j.bcp.2026.118353_b0225","doi-asserted-by":"crossref","first-page":"10591","DOI":"10.1039\/D3FO03643J","article-title":"Ergothioneine suppresses hepatic stellate cell activation via promoting Foxa3-dependent potentiation of the Hint1\/Smad7 cascade and improves CCl4-induced liver fibrosis in mice","volume":"14","author":"Shu","year":"2023","journal-title":"Food Funct."},{"key":"10.1016\/j.bcp.2026.118353_b0230","doi-asserted-by":"crossref","first-page":"110062","DOI":"10.1016\/j.cbi.2022.110062","article-title":"Artemisinin derivative FO-ARS-123 as a novel VEGFR2 inhibitor suppresses angiogenesis, cell migration, and invasion","volume":"365","author":"Lu","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bcp.2026.118353_b0235","doi-asserted-by":"crossref","first-page":"175158","DOI":"10.1016\/j.ejphar.2022.175158","article-title":"Novel artemisinin derivative FO8643 with anti-angiogenic activity inhibits growth and migration of cancer cells via VEGFR2 signaling","volume":"930","author":"Lu","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118353_b0240","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1113\/JP290011","article-title":"Methionine adenosyl-transferase 2A promotes placental angiogenesis by regulating VEGF-A translation via the mTORC1 signalling pathway","volume":"604","author":"Zhou","year":"2026","journal-title":"J. Physiol."},{"key":"10.1016\/j.bcp.2026.118353_b0245","doi-asserted-by":"crossref","first-page":"153332","DOI":"10.1016\/j.phymed.2020.153332","article-title":"Multiple modes of cell death in neuroendocrine tumors induced by artesunate","volume":"79","author":"Yan","year":"2020","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2026.118353_b0250","doi-asserted-by":"crossref","first-page":"177538","DOI":"10.1016\/j.ejphar.2025.177538","article-title":"Targeting sensitive and multidrug resistant leukemia cells with a novel benzofuran-isatin conjugate","volume":"997","author":"Jin","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118353_b0255","doi-asserted-by":"crossref","first-page":"106197","DOI":"10.1016\/j.tiv.2026.106197","article-title":"Conditioned medium from 1-nitropyrene induced THP-1 foam cells promotes pro-tumorigenesis in lung epithelial cells","author":"Bagde","year":"2026","journal-title":"Toxicol. In Vitro"},{"issue":"5","key":"10.1016\/j.bcp.2026.118353_b0260","doi-asserted-by":"crossref","first-page":"751","DOI":"10.18063\/ijb.751","article-title":"A new 3D-printed polylactic acid-bioglass composite for bone tissue engineering induces angiogenesis in vitro and in ovo","volume":"9","author":"Cichos","year":"2023","journal-title":"Int. J. Bioprint."},{"issue":"10","key":"10.1016\/j.bcp.2026.118353_b0265","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.3390\/biomedicines9101462","article-title":"Zinc oxide nanoparticles exhibit favorable properties to promote tissue integration of biomaterials","volume":"9","author":"Wiesmann","year":"2021","journal-title":"Biomedicines"},{"issue":"15","key":"10.1016\/j.bcp.2026.118353_b0270","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.3390\/cells11152321","article-title":"Deep learning-based image analysis for the quantification of tumor-induced angiogenesis in the 3D in vivo tumor model-establishment and addition to laser speckle contrast imaging (LSCI)","volume":"11","author":"Kuri","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2026.118353_b0275","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/978-1-0716-2703-7_10","article-title":"IKOSA\u00ae CAM assay application to quantify blood vessels on chick chorioallantoic membrane (CAM)","volume":"2572","author":"Annese","year":"2023","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118353_b0280","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40729-026-00669-3","article-title":"Boosting angiogenesis experimentally in ovo by biofunctionalizing collagen membranes with platelet-rich fibrin and hyaluronic acid: implications for regenerative oral surgery?","volume":"12","author":"Schr\u00f6ger","year":"2026","journal-title":"Int. J. Implant Dent."},{"key":"10.1016\/j.bcp.2026.118353_b0285","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3389\/fphar.2020.01317","article-title":"Theaflavin induces apoptosis of A375 human melanoma cells and inhibits tumor growth in xenograft zebrafishes through P53- and JNK-related mechanism","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118353_b0290","doi-asserted-by":"crossref","DOI":"10.2991\/978-94-6463-932-2","article-title":"Gymconopin C exhibits anti-non-small cell lung cancer effect by regulating miR-6777-5p\/ADRB2 pathway to promote mitophagy","author":"Li","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.bcp.2026.118353_b0295","doi-asserted-by":"crossref","DOI":"10.1002\/med.70098","article-title":"Artificial intelligence-driven natural product drug discovery: from computational genome mining to clinical translation","author":"Lavecchia","year":"2026","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bcp.2026.118353_b0300","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13287-026-04903-y","article-title":"Fndc5 modification optimizes the therapeutic effect of rat MSCs on sepsis-induced ALI\/ARDS via activating the PI3K\/AKT signaling pathway","volume":"17","author":"Luo","year":"2026","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.bcp.2026.118353_b0305","doi-asserted-by":"crossref","DOI":"10.1007\/s11626-025-01143-x","article-title":"PTIP inhibits proliferation, migration, and angiogenesis of retinal microvascular endothelial cells in a high-glucose environment, In Vitro Cell","author":"Zhang","year":"2026","journal-title":"Dev. Biol. Anim."},{"key":"10.1016\/j.bcp.2026.118353_b0310","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.trsl.2024.03.011","article-title":"Endothelial ELABELA improves post-ischemic angiogenesis by upregulating VEGFR2 expression","volume":"270","author":"Peng","year":"2024","journal-title":"Transl. Res."},{"key":"10.1016\/j.bcp.2026.118353_b0315","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jb\/mvs136","article-title":"Vascular endothelial growth factor and its receptor system: Physiological functions in angiogenesis and pathological roles in various diseases","volume":"153","author":"Shibuya","year":"2013","journal-title":"J. Biochem."},{"key":"10.1016\/j.bcp.2026.118353_b0320","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2026.118353_b0325","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.cellsig.2007.05.013","article-title":"Vascular endothelial growth factor receptor-2: Structure, function, intracellular signalling and therapeutic inhibition","volume":"19","author":"Holmes","year":"2007","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bcp.2026.118353_b0330","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0969-2126(99)80042-2","article-title":"Crystal structure of the kinase domain of human vascular endothelial growth factor receptor 2: a key enzyme in angiogenesis","volume":"7","author":"McTigue","year":"1999","journal-title":"Structure"},{"key":"10.1016\/j.bcp.2026.118353_b0335","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.3390\/molecules29225341","article-title":"Targeting vascular endothelial growth factor receptor 2 (VEGFR-2): latest insights on synthetic strategies","volume":"29","author":"Marques","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2026.118353_b0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4062\/biomolther.2013.113","article-title":"VEGF-VEGFR signals in health and disease","volume":"22","author":"Shibuya","year":"2014","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.bcp.2026.118353_b0345","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1200\/JCO.2009.23.7537","article-title":"Phase I pharmacologic and biologic study of ramucirumab (IMC-1121B), a fully human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2","volume":"28","author":"Spratlin","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bcp.2026.118353_b0350","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0140-6736(15)01088-0","article-title":"Antiangiogenic therapy in oncology: current status and future directions","volume":"388","author":"Jayson","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2026.118353_b0355","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.1039\/D4CP03575E","article-title":"Discovery of potential VEGFR-2 inhibitors from natural products by virtual screening and molecular dynamics simulation","volume":"27","author":"Xie","year":"2025","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.bcp.2026.118353_b0360","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.3390\/ijms27083605","article-title":"Flavonoids as inhibitors of VEGFR2 signaling: structural insights for the development of safer anti-angiogenic therapies","volume":"27","author":"Yim","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118353_b0365","doi-asserted-by":"crossref","first-page":"13880","DOI":"10.1021\/acsomega.4c08366","article-title":"Discovery of novel multiangiogenic agents targeting VEGFR2, EphB4, FGFR-1, and TIE-2: receptor-based pharmacophore modeling, virtual screening, and molecular modeling studies","volume":"10","author":"Patra","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.bcp.2026.118353_b0370","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1158\/1078-0432.CCR-09-2797","article-title":"Vascular endothelial growth factor receptors VEGFR-2 and VEGFR-3 are localized primarily to the vasculature in human primary solid cancers","volume":"16","author":"Smith","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.118353_b0375","article-title":"Fourfold filtered statistical\/computational approach for the identification of imidazole compounds as HO-1 inhibitors from natural products","volume":"113","author":"Floresta","year":"2019","journal-title":"Mar. Drugs"},{"issue":"16","key":"10.1016\/j.bcp.2026.118353_b0380","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1080\/07391102.2020.1794963","article-title":"Prospecting for new catechol-O-methyltransferase (COMT) inhibitors as a potential treatment for Parkinson\u2019s disease: a study by molecular dynamics and structure-based virtual screening","volume":"39","author":"da Silva","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bcp.2026.118353_b0385","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.6c00009","article-title":"MeLysine-Stapling combined with N-Terminal acetylation yields stable oncolytic peptides with enhanced antitumor efficacy","author":"Xu","year":"2026","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2026.118353_b0390","doi-asserted-by":"crossref","first-page":"366","DOI":"10.14740\/wjon2729","article-title":"TRIM33 reverses cisplatin resistance in non-Small cell lung cancer by regulating the PI3K\/AKT pathway via ubiquitination-mediated degradation of LPCAT1","volume":"17","author":"Huang","year":"2026","journal-title":"World J. Oncol."},{"issue":"28","key":"10.1016\/j.bcp.2026.118353_b0395","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.2174\/1568026617666170707123553","article-title":"Arylurea derivatives: a class of potential cancer targeting agents","volume":"17","author":"Chen","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bcp.2026.118353_b0400","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/modpathol.2013.233","article-title":"Tyrosine kinase receptors as molecular targets in pheochromocytomas and paragangliomas","volume":"27","author":"Cassol","year":"2014","journal-title":"Mod. Pathol."},{"issue":"16","key":"10.1016\/j.bcp.2026.118353_b0405","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.2174\/0929867324666170112112734","article-title":"Kinase inhibitors in multitargeted cancer therapy","volume":"24","author":"Gentile","year":"2017","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2026.118353_b0410","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12916-023-02838-2","article-title":"Three tyrosine kinase inhibitors cause cardiotoxicity by inducing endoplasmic reticulum stress and inflammation in cardiomyocytes","volume":"21","author":"Wang","year":"2023","journal-title":"BMC Med"},{"issue":"6","key":"10.1016\/j.bcp.2026.118353_b0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189494","article-title":"Dual faces of angiogenesis: Mechanisms and therapeutic applications","volume":"1880","author":"Izadpanah","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.bcp.2026.118353_b0420","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3390\/bios15040238","article-title":"New frontiers for the early diagnosis of cancer: screening miRNAs through the lateral flow assay method","volume":"15","author":"Emamiamin","year":"2025","journal-title":"Biosensors"},{"key":"10.1016\/j.bcp.2026.118353_b0425","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jconrel.2019.05.019","article-title":"Knockdown of hypoxia-inducible factor-1 alpha by tumor targeted delivery of CRISPR\/Cas9 system suppressed the metastasis of pancreatic cancer","volume":"304","author":"Li","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bcp.2026.118353_b0430","doi-asserted-by":"crossref","first-page":"130","DOI":"10.5551\/jat.13.130","article-title":"Signal transduction via vascular endothelial growth factor (VEGF) receptors and their roles in atherogenesis","volume":"13","author":"Matsumoto","year":"2006","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.bcp.2026.118353_b0435","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/emboj\/20.11.2768","article-title":"A single autophosphorylation site on KDR\/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells","volume":"20","author":"Takahashi","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.bcp.2026.118353_b0440","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/01.ATV.0000110502.10593.06","article-title":"Vascular endothelial growth factor activates PI3K\/Akt\/forkhead signaling in endothelial cells","volume":"24","author":"Abid","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118353_b0445","doi-asserted-by":"crossref","DOI":"10.5812\/ijpr-163152","article-title":"Unveiling the Bioactive potential of Allium colchicifolium boiss bulb flavonoids: anti-cancer activities, and computational exploration of anti-angiogenic mechanisms","volume":"24","author":"Majnooni","year":"2025","journal-title":"Iran J. Pharm. Res."},{"key":"10.1016\/j.bcp.2026.118353_b0450","doi-asserted-by":"crossref","first-page":"114591","DOI":"10.1016\/j.phytochem.2025.114591","article-title":"Discovering VEGFR-targeting constituents from Chloranthus holostegius guided by affinity screening","volume":"239","author":"Liu","year":"2025","journal-title":"Phytochemistry"},{"key":"10.1016\/j.bcp.2026.118353_b0455","doi-asserted-by":"crossref","first-page":"116299","DOI":"10.1016\/j.jep.2023.116299","article-title":"The extract of Curcumae Longae Rhizoma suppresses angiogenesis via VEGF-induced PI3K\/Akt-eNOS-NO pathway","volume":"308","author":"Guo","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bcp.2026.118353_b0460","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.3390\/cancers13061422","article-title":"Role of bFGF in acquired resistance upon anti-VEGF therapy in cancer","volume":"13","author":"Zahra","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bcp.2026.118353_b0465","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3389\/fcell.2020.00584","article-title":"Resistance to anti-angiogenic therapies: a mechanism depending on the time of exposure to the drugs","volume":"8","author":"Montemagno","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118353_b0470","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1158\/1078-0432.CCR-20-2571","article-title":"Camrelizumab in combination with apatinib in patients with advanced hepatocellular carcinoma (RESCUE): a nonrandomized, open-label, phase II trial","volume":"27","author":"Xu","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.bcp.2026.118353_b0475","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00432-012-1162-x","article-title":"Combination of Temsirolimus and tyrosine kinase inhibitors in renal carcinoma and endothelial cell lines","volume":"138","author":"Martin","year":"2012","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.bcp.2026.118353_b0480","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.2174\/0929867324666161118130238","article-title":"MRP1-dependent collateral sensitivity of multidrug-resistant cancer cells: identifying selective modulators inducing cellular glutathione depletion","volume":"24","author":"Lorendeau","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bcp.2026.118353_b0485","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.2174\/1389557521666210112141455","article-title":"Anticancer natural products with collateral sensitivity: a review","volume":"21","author":"Qian","year":"2021","journal-title":"Mini Rev. Med. Chem."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226006921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226006921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:19:48Z","timestamp":1788812388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226006921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":97,"alternative-id":["S0006295226006921"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118353","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of NAT-6-321056 as a novel modulator of VEGFR2 signaling to suppress tumor angiogenesis","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118353","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"118353"}}